Clinical Trials | March 23, 2024
AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer
Combination shows consistent benefit across prespecified post-progression outcomes
Combination shows consistent benefit across prespecified post-progression outcomes
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The drug will target specific genetic mutations prevalent in certain types of cancers
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
The investment will catalyse various components of the IndiaAI Mission
Subscribe To Our Newsletter & Stay Updated
